Gosselies
Belgium
6
2026-04-23
4
2024-09-17
These are the the leading inventors for applications assigned to EPICS THERAPEUTICS:
EPICS THERAPEUTICS based in Gosselies, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
SYNTHESIS OF (2S,5R)-5-(2-CHLOROPHENYL)-1-(2'-METHOXY-[1,1'-BIPHENYL]-4- CARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID
#2 | 2025-01-02PIPERIDINE DERIVATIVES AS METTL3 INHIBITORS
#3 | 2024-08-15 ✅ Patent 12,091,400 granted on 2024-09-17Piperidine derivatives as METTL3 inhibitors
#4 | 2024-04-25 ✅ Patent 12,054,457 granted on 2024-08-06Polymorphs of (2S,5R)-5-(2-chlorophenyl)-1-(2′-methoxy-[1,1′-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereof
#5 | 2023-08-31 ✅ Patent 12,528,769 granted on 2026-01-20SYNTHESIS OF (2S,5R)-5-(2-CHLOROPHENYL)-1-(2'-METHOXY-[1,1'-BIPHENYL]-4- CARBONYL)PYRROLIDINE-2-CARBOXYLIC ACID
#6 | 2018-10-18 ✅ Patent 10,358,416 granted on 2019-07-23Substituted pyrrolidines as G-protein coupled receptor 43 agonists
Also check out EPICS THERAPEUTICS's (Gosselies, Belgium) applicant profile with 5 patent applications submitted.
340992 ⎘